These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32512705)

  • 1. G9a Is SETting the Stage for Colorectal Oncogenesis.
    Bergin CJ; Benoit YD
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32512705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Bergin CJ; Zouggar A; Haebe JR; Masibag AN; Desrochers FM; Reilley SY; Agrawal G; Benoit YD
    Oncogene; 2021 Feb; 40(6):1191-1202. PubMed ID: 33323965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis.
    Kato S; Weng QY; Insco ML; Chen KY; Muralidhar S; Pozniak J; Diaz JMS; Drier Y; Nguyen N; Lo JA; van Rooijen E; Kemeny LV; Zhan Y; Feng Y; Silkworth W; Powell CT; Liau BB; Xiong Y; Jin J; Newton-Bishop J; Zon LI; Bernstein BE; Fisher DE
    Cancer Discov; 2020 Jul; 10(7):980-997. PubMed ID: 32269030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
    Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
    Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
    Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
    Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.
    Cha ST; Tan CT; Chang CC; Chu CY; Lee WJ; Lin BZ; Lin MT; Kuo ML
    Nat Cell Biol; 2016 Sep; 18(9):993-1005. PubMed ID: 27525719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation.
    Zhang J; He P; Xi Y; Geng M; Chen Y; Ding J
    Oncotarget; 2015 Feb; 6(5):2917-27. PubMed ID: 25595900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of
    Dobson THW; Hatcher RJ; Swaminathan J; Das CM; Shaik S; Tao RH; Milite C; Castellano S; Taylor PH; Sbardella G; Gopalakrishnan V
    Mol Cancer Res; 2017 Aug; 15(8):1073-1084. PubMed ID: 28483947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis.
    Tu WB; Shiah YJ; Lourenco C; Mullen PJ; Dingar D; Redel C; Tamachi A; Ba-Alawi W; Aman A; Al-Awar R; Cescon DW; Haibe-Kains B; Arrowsmith CH; Raught B; Boutros PC; Penn LZ
    Cancer Cell; 2018 Oct; 34(4):579-595.e8. PubMed ID: 30300580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low G9a expression is a tumor progression factor of colorectal cancer via IL-8 promotion.
    Ichikawa Y; Takahashi H; Chinen Y; Arita A; Sekido Y; Hata T; Ogino T; Miyoshi N; Uemura M; Yamamoto H; Mizushima T; Doki Y; Eguchi H
    Carcinogenesis; 2022 Sep; 43(8):797-807. PubMed ID: 35640269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling.
    Li J; Yu B; Deng P; Cheng Y; Yu Y; Kevork K; Ramadoss S; Ding X; Li X; Wang CY
    Nat Commun; 2017 Apr; 8():15146. PubMed ID: 28440295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation.
    Pan MR; Hsu MC; Chen LT; Hung WC
    Sci Rep; 2015 Dec; 5():18709. PubMed ID: 26688070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of
    Zhang J; Wang Y; Shen Y; He P; Ding J; Chen Y
    Theranostics; 2018; 8(10):2884-2895. PubMed ID: 29774081
    [No Abstract]   [Full Text] [Related]  

  • 16. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
    Lin X; Huang Y; Zou Y; Chen X; Ma X
    Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression.
    Chang CC; Wu MJ; Yang JY; Camarillo IG; Chang CJ
    Cancer Res; 2015 Jun; 75(11):2375-2386. PubMed ID: 25840984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin.
    Wang YF; Zhang J; Su Y; Shen YY; Jiang DX; Hou YY; Geng MY; Ding J; Chen Y
    Nat Commun; 2017 Aug; 8(1):274. PubMed ID: 28819251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.
    Liu CW; Hua KT; Li KC; Kao HF; Hong RL; Ko JY; Hsiao M; Kuo ML; Tan CT
    Mol Cancer Ther; 2017 Jul; 16(7):1421-1434. PubMed ID: 28265008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.